During the past decade, MAV Korhaz és Rendelointezet conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MAV Korhaz és Rendelointezet" #1 sponsor was "Amgen" with 3 trials, followed by "R-Pharm International, LLC" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MAV Korhaz és Rendelointezet" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "MAV Korhaz és Rendelointezet" are "Rheumatoid Arthritis" (4 trials), "Psoriatic Arthritis" (3 trials), "Arthritis, Psoriatic" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "MAV Korhaz és Rendelointezet" in a lesser frequency.

Most popular intervention types in "MAV Korhaz és Rendelointezet" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Adalimumab 40mg q2w" (1 trials) and "Apremilast 30 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "MAV Korhaz és Rendelointezet" are 12 trials for "All" genders.

Currently, there are NaN active trials in "MAV Korhaz és Rendelointezet". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in MAV Korhaz és Rendelointezet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MAV Korhaz és Rendelointezet, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

MAV Korhaz és Rendelointezet has several departments that took part in Clinical trials: "MAV Korhaz es Rendelointezet, Reumatologiai szakrendeles" - 2 trials